Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

    June 8, 2023

    Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

    June 7, 2023

    Biotechs face challenges as the industry’s annual bash returns to Boston

    June 5, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

      June 8, 2023

      Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

      June 7, 2023

      Biotechs face challenges as the industry’s annual bash returns to Boston

      June 5, 2023

      The Biotech Buying Bonanza: Why The FTC’s Amgen Battle Won’t Chill The Spree

      June 5, 2023

      China reaching for biotech breakthroughs in space

      June 2, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Pharmaceutical»Nykaa, Asian Paints, Torrent Pharma and more: Key stocks that moved the most on September 29
    Pharmaceutical

    Nykaa, Asian Paints, Torrent Pharma and more: Key stocks that moved the most on September 29

    yourbiotechBy yourbiotechSeptember 29, 2022Updated:November 11, 2022No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Torrent Pharma | The shares of Torrent Pharmaceuticals Ltd jumped 3.3 percent on September 29 after the US Food and Drug Administration issued a ‘Form 483’ with 3 observations for the company’s manufacturing facility at Indrad, Gujarat. The company has, however, clarified that none of these observations were related to data integrity.  Its stock ended 3.6 percent higher.

    Asian Paints Ltd | Nifty50’s top loser, its stock ended 4.7 percent down.

    The Ramco Cements Ltd | Shares of Ramco Cements Ltd rose as much as 2.2 percent on Thursday, a day after the company said it had commissioned a fifth integrated cement plant with a clinkerisation capacity of 2.25 million tonnes per annum at Kolumigundla, Kurnool District, Andhra Pradesh. Its stock ended 1.1 percent higher.Lupin Ltd | The shares of Lupin Ltd fell 2.7 percent on Thursday after the company’s Tarapur Plant received a warning letter from the US Food and Drug Administration (US FDA). The US FDA inspected the company’s Tarapur plant from March 22 to April 4. Its stock ended 2.1 percent down.

    Jindal Steel & Power Ltd | The Australian division of Jindal Steel and Power (JSPL) paid back the last loan instalment on Wednesday. At its peak, overseas debt was $1.8 billion, which has been brought down to nil through a combination of repayments and divestments. Its shares rose over 4 percent in today’s trading session. The stock closed nearly 3.8 percent higher.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleSee the presentations that cutting-edge biotech companies have used to raise millions from top investors
    Next Article Novel CRISPR-based method benefits further cancer studies
    yourbiotech
    • Website

    Related Posts

    Pharma company owner duped of ₹1.1 crore

    November 11, 2022

    Novavax cuts full-year revenue forecast again amid weak demand

    November 10, 2022

    Aurobindo units recall products in US market for manufacturing issues

    November 9, 2022

    AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

    November 8, 2022

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.